Lead: Public health approaches to gamblingLead: Public health approaches to gambling
This Week in Addiction Medicine from ASAM
Lead Story: Public health approaches to gambling: a global review of legislative trends The Lancet Public Health Authors of this article systematically reviewed legislation of jurisdictions that introduced major gambling legislation change (i.e., re...
6:49•15 Nov 2023
Gambling Legislation and Addiction Medicine: Global Trends and Key Insights
Episode Overview
- Global review of legislative trends in gambling highlights individual-level harm focus
- Bupropion shows potential for reducing stimulant use in amphetamine-type substance use disorder
- Postmortem toxicology findings reveal prevalent presence of fentanyl in opioid overdose cases
- Severe trauma exposure in late childhood linked to adverse outcomes in drug use disorder treatment
- Perspective on FDA evaluation of psychedelic medicine prompts thoughtful consideration for mental health treatment
“Most of the proposed prevention measures focused on individual responsibility, showcasing the way that gambling as a public health issue has not yet translated into comprehensive policy action across jurisdictions.”
Gambling is more than just a game; it's a public health issue affecting millions worldwide. In this episode of 'Addiction Medicine Unpacked', Claire Rasmussen dives into a global review of legislative trends in gambling, as featured in The Lancet Public Health. She highlights the shift towards recognizing harmful gambling as a health and wellbeing concern, yet notes that most policies still focus on individual responsibility rather than broader social and economic impacts. This episode isn't just about gambling, though.
You'll also hear about the effectiveness of bupropion for amphetamine-type substance use disorder, intriguing postmortem toxicology findings from the Camden Opioid Research Initiative, and how severe trauma exposure can affect treatment outcomes for drug use disorders. And if you're curious about the future of psychedelic medicine, stick around for a fascinating discussion on how the FDA should approach its evaluation.
Whether you're a healthcare professional, a student, or someone touched by addiction, this episode offers valuable insights and timely discussions on critical topics in addiction medicine.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.